Trovirdine
Alternative Names: LY 300046; LY 300046.HCl; LY 300082; PETT 1Latest Information Update: 20 Dec 1999
At a glance
- Originator Medivir AB
- Developer Eli Lilly and Company; Medivir AB
- Class Antiretrovirals
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported HIV-1 infections